A Study of STSA-1002 Combined With STSA-1005 in Healthy Subjects

Clinical trial NCT05559125 · TERMINATED

Trial details

NCT number: NCT05559125
Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subject

Start date: 2022-11-08
Primary completion: 2024-03-26
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.